Advances Against Aspergillosis I
Medical Science, Volume 1272
Herausgeber: Clemons, Karl V; Perlin, David S; Richardson, Malcolm D
Advances Against Aspergillosis I
Medical Science, Volume 1272
Herausgeber: Clemons, Karl V; Perlin, David S; Richardson, Malcolm D
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
"The papers included in two volumes of Annals of the New York Academy of Sciences provide a cross-section of the information presented at the 5th 'Advances Against Aspergillosis'"--Page viii.
Andere Kunden interessierten sich auch für
- Advances Against Aspergillosis II98,99 €
- Enas Mahmoud AmerIncidence of fungi and mycotoxins incriminated for human aspergillosis44,99 €
- Recent Advances in Human Fungal Diseases183,99 €
- Antimicrobial Therapeutics Reviews154,99 €
- The Role of Nonliving Organic Matter in the Earth's Carbon Cycle621,99 €
- Bacterial Adhesion375,99 €
- Prakash S BisenEmerging Epidemics216,99 €
-
-
-
"The papers included in two volumes of Annals of the New York Academy of Sciences provide a cross-section of the information presented at the 5th 'Advances Against Aspergillosis'"--Page viii.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley
- Seitenzahl: 252
- Erscheinungstermin: 22. Januar 2013
- Englisch
- Abmessung: 249mm x 175mm x 5mm
- Gewicht: 204g
- ISBN-13: 9781573318549
- ISBN-10: 157331854X
- Artikelnr.: 36877213
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Wiley
- Seitenzahl: 252
- Erscheinungstermin: 22. Januar 2013
- Englisch
- Abmessung: 249mm x 175mm x 5mm
- Gewicht: 204g
- ISBN-13: 9781573318549
- ISBN-10: 157331854X
- Artikelnr.: 36877213
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Karl V Clemons, Stanford University, Stanford, California. Malcolm Richardson, University of Manchester, Manchester, United Kingdom. David S Perlin, UMDNJ-New Jersey Medical School, Newark, New Jersey.
Preface for Advances Against Aspergillosis Karl V. demons David S. Perlin
Malcolm Richardson vii
Aspergillosis in the Clinic
Application of diagnostic markers to invasive aspergillosis in children
Emmanuel Roilides Zoi-Dorothea Pana 1
Azole resistance in Aspergillus: global status in Europe and Asia Sevtap
Arikan-Akdagli 9
The impact of azole resistance on aspergillosis guidelines Sarah P.
Georgiadou Dimitrios P. Kontoyiannis 15
Risk stratification for invasive aspergillosis in immunocompromised
patients Raoul Herbrecht Pierre Bories Jean-Charles Moulin Marie-Pierre
Ledoux Valérie Letscher-Bru 23
Invasive aspergillosis in the intensive care unit George Dimopoulos
Frantezeska Frantzeskaki Garyfallia Poulakou Apostolos Armaganidis 31
Management of chronic pulmonary aspergillosis Koichi Izumikawa Masato
Tashiro Shigeru Kohno 40
The use of biological agents for the treatment of fungal asthma and
allergic bronchopulmonary aspergillosis Richard B. Moss 49
Multifocal pulmonary aspergillomas: case series and review Matthew
Pendleton David W. Denning 58
Immune regulation in idiopathic bronchiectasis Rosemary J. Boyton Daniel M.
Altmann 68
Aspergillus bronchitis without significant immunocompromise Ales Chrdle
Sahlawati Mustakim Rowland J. Bright-Thomas Caroline G. Baxter Timothy
Felton David W. Denning 73
Malcolm Richardson vii
Aspergillosis in the Clinic
Application of diagnostic markers to invasive aspergillosis in children
Emmanuel Roilides Zoi-Dorothea Pana 1
Azole resistance in Aspergillus: global status in Europe and Asia Sevtap
Arikan-Akdagli 9
The impact of azole resistance on aspergillosis guidelines Sarah P.
Georgiadou Dimitrios P. Kontoyiannis 15
Risk stratification for invasive aspergillosis in immunocompromised
patients Raoul Herbrecht Pierre Bories Jean-Charles Moulin Marie-Pierre
Ledoux Valérie Letscher-Bru 23
Invasive aspergillosis in the intensive care unit George Dimopoulos
Frantezeska Frantzeskaki Garyfallia Poulakou Apostolos Armaganidis 31
Management of chronic pulmonary aspergillosis Koichi Izumikawa Masato
Tashiro Shigeru Kohno 40
The use of biological agents for the treatment of fungal asthma and
allergic bronchopulmonary aspergillosis Richard B. Moss 49
Multifocal pulmonary aspergillomas: case series and review Matthew
Pendleton David W. Denning 58
Immune regulation in idiopathic bronchiectasis Rosemary J. Boyton Daniel M.
Altmann 68
Aspergillus bronchitis without significant immunocompromise Ales Chrdle
Sahlawati Mustakim Rowland J. Bright-Thomas Caroline G. Baxter Timothy
Felton David W. Denning 73
Preface for Advances Against Aspergillosis Karl V. demons David S. Perlin
Malcolm Richardson vii
Aspergillosis in the Clinic
Application of diagnostic markers to invasive aspergillosis in children
Emmanuel Roilides Zoi-Dorothea Pana 1
Azole resistance in Aspergillus: global status in Europe and Asia Sevtap
Arikan-Akdagli 9
The impact of azole resistance on aspergillosis guidelines Sarah P.
Georgiadou Dimitrios P. Kontoyiannis 15
Risk stratification for invasive aspergillosis in immunocompromised
patients Raoul Herbrecht Pierre Bories Jean-Charles Moulin Marie-Pierre
Ledoux Valérie Letscher-Bru 23
Invasive aspergillosis in the intensive care unit George Dimopoulos
Frantezeska Frantzeskaki Garyfallia Poulakou Apostolos Armaganidis 31
Management of chronic pulmonary aspergillosis Koichi Izumikawa Masato
Tashiro Shigeru Kohno 40
The use of biological agents for the treatment of fungal asthma and
allergic bronchopulmonary aspergillosis Richard B. Moss 49
Multifocal pulmonary aspergillomas: case series and review Matthew
Pendleton David W. Denning 58
Immune regulation in idiopathic bronchiectasis Rosemary J. Boyton Daniel M.
Altmann 68
Aspergillus bronchitis without significant immunocompromise Ales Chrdle
Sahlawati Mustakim Rowland J. Bright-Thomas Caroline G. Baxter Timothy
Felton David W. Denning 73
Malcolm Richardson vii
Aspergillosis in the Clinic
Application of diagnostic markers to invasive aspergillosis in children
Emmanuel Roilides Zoi-Dorothea Pana 1
Azole resistance in Aspergillus: global status in Europe and Asia Sevtap
Arikan-Akdagli 9
The impact of azole resistance on aspergillosis guidelines Sarah P.
Georgiadou Dimitrios P. Kontoyiannis 15
Risk stratification for invasive aspergillosis in immunocompromised
patients Raoul Herbrecht Pierre Bories Jean-Charles Moulin Marie-Pierre
Ledoux Valérie Letscher-Bru 23
Invasive aspergillosis in the intensive care unit George Dimopoulos
Frantezeska Frantzeskaki Garyfallia Poulakou Apostolos Armaganidis 31
Management of chronic pulmonary aspergillosis Koichi Izumikawa Masato
Tashiro Shigeru Kohno 40
The use of biological agents for the treatment of fungal asthma and
allergic bronchopulmonary aspergillosis Richard B. Moss 49
Multifocal pulmonary aspergillomas: case series and review Matthew
Pendleton David W. Denning 58
Immune regulation in idiopathic bronchiectasis Rosemary J. Boyton Daniel M.
Altmann 68
Aspergillus bronchitis without significant immunocompromise Ales Chrdle
Sahlawati Mustakim Rowland J. Bright-Thomas Caroline G. Baxter Timothy
Felton David W. Denning 73